Table: begin end state 1 21 non-cytoplasmic 22 44 transmembrane 45 55 cytoplasmic 56 74 transmembrane 75 97 non-cytoplasmic 98 121 transmembrane 122 133 cytoplasmic 134 155 transmembrane 156 160 non-cytoplasmic 161 182 transmembrane 183 192 cytoplasmic 193 221 transmembrane 222 240 non-cytoplasmic 241 259 transmembrane 260 272 cytoplasmic 273 294 transmembrane 295 299 non-cytoplasmic 300 300 transmembrane 301 324 non-cytoplasmic 325 350 transmembrane 351 354 cytoplasmic 355 381 transmembrane 382 382 non-cytoplasmic 383 392 cytoplasmic 393 394 non-cytoplasmic 395 395 cytoplasmic 396 415 transmembrane 416 420 cytoplasmic 421 443 transmembrane 444 447 non-cytoplasmic 448 453 cytoplasmic 454 454 non-cytoplasmic 455 481 transmembrane 482 482 non-cytoplasmic 483 498 cytoplasmic 499 532 transmembrane 533 546 non-cytoplasmic 547 573 transmembrane 574 586 cytoplasmic 587 609 transmembrane 610 615 non-cytoplasmic
Input: >RR42_RS10605 MGFHQDNEAGRWLAWLTRSLEYMSGAVLALDVLIVFLSVVYRYFLHDPVDWAEEIARALM VVLVFFGAATVLARSQHVGIDLFRGLLPVRWQPLLIQAGHWIIAGVSASLLVSSVLLLVD SYDQTTSIGLPQWLYVYPVVFGSAFMTLFALANAVSGSRGVVWRAFVTCAVLAAAVTAWN VLVPEHAISRGALLAIGFIGALVLGVPIGFVLAFAALLYFLADPSLPMLVYSQQVMAGTD HFVLLAIPFFVLAGLLMEANGMSSRLIELLLRVFGRVRGGLGLITIIATAFFSGVSGSKL ADVAAVGGIVMPAVRRTRQDPGEAAGLLACSAVMAETIPPCINLILMGFVANISIAGLFM AGLVPAAVMALSLAVLAVIVGRKINPDEAFEHRTPLWPLLGGALVALIMVGMIGKGVTSG IATSTEVSAFAVVYALVVGGLAFRELNLRSVARLFVRSASMAGGILFIVAAASSVSFALT IEQIPQLMSGTMTAFAAQYGSVMFIMLSALLMMVFGAVLEGAPALIIFGPLLTPIAQQLG VNPLHFGTVMVIAMGLGLFAPPVGLGLFATCAITGTQVKDVARPMLKYLAVLLVALVLLI LVPAFSLWLPNRLGM
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server